Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Microneedle-Based Transdermal Drug Delivery: Recent Advances and Future Prospects
Abstract: Microneedle (MN) systems are emerging as versatile platforms that create micron-scale pathways across the stratum corneum while limiting stimulation of deeper pain receptors and blood vessels.This minimally invasive approach expands transdermal delivery beyond the small, moderately lipophilic molecules traditionally suited to passive patches and enables administration of peptides, proteins, vaccines, poorly soluble drugs, nucleic-acid formulations and locally acting dermatological agents.This review critically examines solid, coated, hollow, dissolving, separable and hydrogel-forming microneedles, with emphasis on how material selection, needle geometry, drug localization and manufacturing method determine insertion reliability, dose capacity, release kinetics and product stability.Recent advances include pure-drug needle tips for high payloads, nanosuspension-loaded dissolving arrays for lipophilic molecules, hydrogel-forming systems coupled with engineered reservoirs, rapidly separating tips for sustained intradermal depots, and additive manufacturing for rapid design optimization.Clinical evidence from influenza, measles-rubella and osteoporosis programmes confirms the translational potential of microarray patches, although local reactions, dose delivery variability and scale-up remain important constraints.Critical quality attributes include morphology, mechanical strength, insertion depth, drug content and distribution, dissolution or swelling, permeation, sterility assurance, packaging integrity and user-applied force.Future progress will depend on integrated quality-by-design development, robust in vitro-in vivo relationships, climate-resilient packaging, humanfactor engineering and clearer combination-product regulatory pathways.Microneedles are therefore positioned not merely as an alternative to injections, but as a programmable interface for localized, systemic and responsive therapy.